USP1 and Ewing sarcoma: Upon further investigation of the mechanism of differential chemotherapy sensitivity of the CD133high and CD133low populations, we found that USP1 is a transcriptional activation target of EWS-FLI1 and is a key determinant of chemotherapy sensitivity in Ewing sarcoma.